跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Abilify - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Abilify
Approved
STANDARD
Abilify
Korea Otsuka Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
021714371dd29ae7
Company
Korea Otsuka Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
021714371dd29ae7
Drug Approval Philippines Name
Abilify
Product Name
Abilify
Registration Number
DRP-6283
Brand Name
Abilify
Generic Name
Aripiprazole
Dosage Form
Tablet
Dosage Strength
15mg
Manufacturer
Korea Otsuka Pharmaceutical Co., Ltd.
Importer
Otsuka (Philippines) Pharmaceutical, Inc.
Distributor
ZUELLIG PHARMA CORPORATION
Company Detail Path
/organization/korea-otsuka-pharmaceutical-co-ltd
Importer Detail Path
/organization/otsuka-philippines-pharmaceutical-inc
Issuance Date
28 July 2021
Expiry Date
13 September 2026
Pharmacologic Category
ANTIPSYCHOTIC
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
021714371dd29ae7
Type
Standard
Back to Philippines FDA Approvals